Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix
Washington, DC – October 11, 2016 – New research led by scientists from the University of Maryland, Baltimore demonstrated that when grown together, the fungus Candida albicans provides the bacterium Staphylococcus aureus with enhanced tolerance to antimicrobial drugs. These two pathogens are responsible for the majority of most of the infections in hospitalized patients and are often coisolated from a host. This research could have therapeutic implications, as understanding the interactions between these two diverse microbial species will aid in overcoming the limitations of current therapies and in defining new targets for treating complex polymicrobial infections. The research was published this week in mBio, an open-access journal of the American Society for Microbiology.
The full study can be read online at: http://mbio.asm.org/content/7/5/e01365-16.